s ▁and ▁ 9 9 ▁percent ▁of ▁children ▁with ▁H IV ▁live . ▁Also ▁in ▁ 2 0 1 3 ▁G SK ▁joined ▁All Tri als , ▁a ▁British ▁campaign ▁to ▁ensure ▁that ▁all ▁clin ical ▁tri als ▁are ▁registered ▁and ▁the ▁results ▁reported . ▁The ▁company ▁said ▁it ▁would ▁make ▁its ▁past ▁clin ical - tri al ▁reports ▁available ▁and ▁future ▁ones ▁within ▁a ▁year ▁of ▁the ▁studies ' ▁end . ▁ ▁Cont ro vers ies ▁▁ 2 0 1 2 ▁criminal ▁and ▁civil ▁settlement ▁ ▁Over view ▁In ▁July ▁ 2 0 1 2 , ▁G SK ▁ple aded ▁guilty ▁in ▁the ▁United ▁States ▁to ▁criminal ▁charges , ▁and ▁agreed ▁to ▁pay ▁US $ 3 b ill ion , ▁in ▁what ▁was ▁the ▁largest ▁settlement ▁until ▁then ▁between ▁the ▁Justice ▁Department ▁and ▁a ▁drug ▁company . ▁The ▁US $ 3 b ill ion ▁included ▁a ▁criminal ▁fine ▁of ▁US $ 9 5 6 , 8 1 4 , 4 0 0 ▁and ▁for fe iture ▁of ▁US $ 4 3 , 1 8 5 , 6 0 0 . ▁The ▁remaining ▁US $ 2 b ill ion ▁covered ▁a ▁civil ▁settlement ▁with ▁the ▁government ▁under ▁the ▁False ▁Cla ims ▁Act . ▁The ▁investigation ▁was ▁launched ▁largely ▁on ▁the ▁basis ▁of ▁information ▁from ▁four ▁wh ist leb low ers ▁who ▁file d ▁qui ▁tam ▁( wh ist leb lower ) ▁law su its ▁against ▁the ▁company ▁under ▁the ▁False ▁Cla ims ▁Act . ▁ ▁The ▁charges ▁stem med ▁from ▁G SK '